We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BRAF

News List

Combining drugs that target BRAF and HSP90 shows success for melanoma patients europeanpharmaceuticalreview
April 26, 2018
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
MK-8353 shows promise for melanoma with BRAF or RAS mutations europeanpharmaceuticalreview
February 28, 2018
An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial…
Horizon Discovery introduces four BRAF resistant melanoma PDX models pharmaasia
June 08, 2017
PDX models of tumors offer better in vivo insights for cancer research and drug development. These highly characterized models were originally exclusively licensed from The Wistar Insitute